
No data
No data
No data
| CAS Number | 129618-40-2 |
| Catalog Number | AG0080HY(AGN-PC-07A24E) |
| Chemical Name | Nevirapine |
| EC Number | 603-345-0 |
| IUPAC Name | 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one |
| InChI | InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20) |
| InChI Key | NQDJXKOVJZTUJA-UHFFFAOYSA-N |
| MDL Number | MFCD00866928 |
| Molecular Formula | C15H14N4O |
| Molecular Weight | 266.2979 |
| SMILES | O=C1C2=CC=CN=C2N(C3CC3)C4=NC=CC(C)=C4N1 |
| UNII | 99DK7FVK1H |
| Synonyms | BI RG 587,
BI-RG-587,
BIRG587,
Hemihydrate, Nevirapine,
Nevirapine,
Nevirapine Hemihydrate,
Viramune,
nevirapine,
129618-40-2,
Viramune,
BI-RG-587,
Viramune XR,
NVP,
BIRG 0587,
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one,
UNII-99DK7FVK1H,
11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE,
Nevirapine anhydrous,
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one,
Nevirapine (Viramune),
BI-RG 587,
BIRG-0587,
HSDB 7164,
CHEMBL57,
NEV,
NSC 641530,
99DK7FVK1H,
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one,
11-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6(11H)-ONE,
MLS000084585,
NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE,
C15H14N4O,
CHEBI:63613,
NQDJXKOVJZTUJA-UHFFFAOYSA-N,
Nevirapine, 98%,
MFCD00866928,
NSC641530,
6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-,
NCGC00065890-02,
SMR000048458,
DSSTox_CID_10787,
DSSTox_RID_78889,
DSSTox_GSID_31797,
2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one,
BIRG587,
Nevirapine [USAN:INN],
Viramune(TM),
Viramune (TN),
CAS-129618-40-2,
Nevirapine & CD4-IgG,
Nevirapine & PRO 140,
Nevirapine (JAN/USP/INN),
11-cyclopropyl-4-methyl-5H-dipyrido[[?],[?]][1,4]diazepin-6-one,
BIRG 587,
BIRG-587,
11-cyclopropyl-4-methyl-5H-dipyrido[2,3-b:3',2'-e][1,4]diazepin-6-one,
Viramune IR,
1vrt,
2hny,
Nevirapine,(S),
Nevirapine [USAN:USP:INN:BAN],
BI-RG-587 & CD4-IgG,
Opera_ID_934,
Viramune;BI-RG 587,
SCHEMBL3318,
MLS000759409,
MLS001055309,
MLS001201730,
MLS001424058,
MLS006011423,
BIDD:GT0326,
AC1L1I81,
BDBM1434,
ZINC4778,
DTXSID7031797,
CTK8E7455,
KS-00000KZF,
HMS2051J09,
HMS2231O23,
HMS3264D21,
HMS3371E03,
HMS3393J09,
HMS3655I08,
HMS3715B10,
Pharmakon1600-01503842,
ALBB-027264,
BCP05587,
Tox21 110982,
Tox21_110982,
Tox21_200770,
AC-643,
BBL010768,
NSC759902,
STK580320,
AKOS005504351,
Tox21_110982_1,
AB07544,
CCG-100939,
CS-2252,
DB00238,
KS-5019,
LS-2289,
MCULE-8608154492,
NC00189,
NSC-641530,
NSC-759902,
RL01415,
NCGC00065890-03,
NCGC00065890-04,
NCGC00065890-05,
NCGC00065890-07,
NCGC00258324-01,
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody),
AJ-08226,
AK143126,
AN-15635,
BC206673,
CPD000048458,
H954,
HY-10570,
N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin,
SAM001246551,
SC-17266,
SY009679,
ZB000592,
AB0013383,
AB2000266,
RT-014690,
FT-0607215,
N0922,
R3924,
S1742,
ST24038235,
SW197569-2,
11-Cyclopropyl-4-methyl-5H-dipyrido[3,2-b,
MFCD00866928 (98%),
C07263,
D00435,
AB00393001-13,
AB00393001-15,
AB00393001_16,
AB00393001_17,
618N402,
I02-0310,
F2173-0607,
Z1695906730,
Nevirapine (anhydrous), European Pharmacopoeia (EP) Reference Standard,
Nevirapine anhydrous, United States Pharmacopeia (USP) Reference Standard,
Nevirapine solution, 1.0 mg/mL in methanol, certified reference material,
Nevirapine, Pharmaceutical Secondary Standard; Certified Reference Material,
11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido-[3,2-b:2',3'-e][1,4]diazepin-6-one,
11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b :2',3'-e][1,4 ]diazepin-6-one,
11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one,
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2', 3'-e][1,4]diazepin-6-one,
5H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 5,11-dihydro-11-cyclopropyl-4-methyl-,
6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-,
Nevirapine for peak identification, European Pharmacopoeia (EP) Reference Standard,
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2 inverted exclamation mark ,3 inverted exclamation mark -e][1,4]diazepin-6-one,
2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0(3),]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one,
2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0;{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one,
Netobimin,
Nevirapine hemihydrate,
NEVARAPINE,
Hemihydrate, Nevirapine,
D0O2EM,
Promeco Brand of Nevirapine,
BI RG 587,
CID4463,
DRG-0116,
Viramune, BI-RG 587, Nevirapine,
C15-H14-N4-O,
Cahill May Roberts Brand of Nevirapine,
CS-O-01945,
A8481,
A10639,
D019829,
Nevirapine, 99%, Non-nucleoside reverse transcriptase inhibitor (NNRTI) - 100MG 100mg,
|
| Complexity | 397 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 266.117g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 20 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 266.304g/mol |
| Monoisotopic Mass | 266.117g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 58.1A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code | \N |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

